APC and cancer: Identification of diverse nuclear regulators further supports that the activation of dysregulated Wnt pathway in cancer extends beyond genetic mutations, such as those involved in APC or CTNNB1. It is clear that future studies will be required to elucidate the mechanistic connection between these regulators.